Machine learning-based imaging biomarkers improve statistical power in clinical trials - Lou, Carolyn; Habes, Mohamad; Davatzikos, Christos; Shinohara, Russell T. (medRxiv, 2019)
Radiomic models, which leverage complex imaging patterns and machine learning, are increasingly accurate in predicting patient response to treatment and clinical outcome on an individual patient basis. In this work, we show that this predictive power can be utilized in clinical trials to significantly increase statistical power to detect treatment effects or reduce the sample size required to achieve a given power. Akin to the historical control paradigm, we propose to utilize a radiomic prediction model to generate a pseudo-control sample for each individual in the trial of interest. We then incorporate these pseudo-controls into the analysis of the clinical trial of interest using classical and well established statistical tools, and investigate statistical power. Effectively, this approach utilizes each individual’s radiomics-based predictor of outcome for comparison with the actual outcome, potentially increasing statistical power considerably, depending on the accuracy of the predictor. In simulations of treatment effects based on real radiomic predictive models from brain cancer and prodromal Alzheimer’s Disease, we show that this methodology can decrease the required sample sizes by as much as a half, depending on the strength of the radiomic predictor. We further find that this method is most helpful when treatment effect sizes are small and that power grows with the accuracy of radiomic prediction.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by NIH grants R01NS085211, R01MH112847, R01NS060910, RF1AG054409, R01EB022573, R01NS042645, and R01MH112070.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesAll SPARE-AD scores used herein have been uploaded to http://adni.loni.ucla.edu/. All image processing software used to derive SPARE-AD, importantly the DRAMMS deformable registration and COMPARE classification pipelines, are freely available for download under http://www.rad.upenn.edu/sbia, and involve fully automated procedures. Data for the GBM analysis are not publicly available.http://adni.loni.ucla.edu/. http://www.rad.upenn.edu/sbia